Back
BioLine Rx Vs. Can Fite Biofarma Industry Stock Comparison
Sell
32
BLRX
BioLine Rx
Last Price:
0.43
Seasonality Move:
4.46%
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.19
Seasonality Move:
-3.85%
Sell
32
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy, Sell or Hold?
- The current BioLine Rx [BLRX] share price is $0.43. The Score for BLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $2.15. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BLRX Stock Price Chart
What is BioLine Rx's stock price today?
-
The BioLine Rx share price today is $0.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight buying pressure.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $2.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.
BLRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 38.59 | Sell |
Chaikin Money Flow: | 17218 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.42 - 0.5) | Sell |
Bollinger Bands (100): | (0.5 - 0.74) | Sell |
CANF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 39.41 | Sell |
Chaikin Money Flow: | -97705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.04 - 2.66) | Sell |
Bollinger Bands (100): | (2.1 - 3.16) | Sell |
BLRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.42 | Buy |
20-day SMA: | 0.45 | Sell |
50-day SMA: | 0.55 | Sell |
200-day SMA: | 0.78 | Sell |
8-day EMA: | 0.43 | Sell |
20-day EMA: | 0.46 | Sell |
50-day EMA: | 0.53 | Sell |
200-day EMA: | 0.78 | Sell |
CANF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.31 | Sell |
20-day SMA: | 2.44 | Sell |
50-day SMA: | 2.29 | Sell |
200-day SMA: | 2.4 | Sell |
8-day EMA: | 2.3 | Sell |
20-day EMA: | 2.36 | Sell |
50-day EMA: | 2.39 | Sell |
200-day EMA: | 2.51 | Sell |
BioLine Rx Earnings Growth & BLRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
BioLine Rx Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Can Fite Biofarma Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |